Previous Article | Next Article ![]()
Journal of Clinical Microbiology, September 2000, p. 3306-3310, Vol. 38, No. 9
Institute of
Microbiology,1 Graduate Institute of
Medical Technology,2 and College of
Medicine, Institute of Epidemiology,4
College of Public Health, National Taiwan University, and
Institute of Biomedical Sciences, Academia
Sinica,3 Taipei, Taiwan
Received 11 February 2000/Returned for modification 19 May
2000/Accepted 5 July 2000
A quantitative competitive reverse transcription-PCR assay was
developed to quantify dengue virus RNA in this study. The main features
include a primer pair targeting a highly conserved region in the capsid
and the addition of competing RNA that contains an internal deletion to
provide a stringent internal control for quantification. It can be
utilized to quantify RNA isolated from the four dengue virus serotypes
but not RNA isolated from other flaviviruses, including Japanese
encephalitis virus and hepatitis C virus, both prevalent in Asia. It
can also be used to quantify dengue virus RNA isolated from the plasma
of infected individuals. The sensitivity of the assay was estimated to
be 10 to 50 copies of RNA per reaction, and twofold differences in
virus titer are distinguishable. This assay is a convenient, sensitive,
and accurate method for quantification and can be used to further
understanding of the pathogenesis of dengue virus infection.
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Quantitative Competitive Reverse Transcription-PCR
for Quantification of Dengue Virus RNA
*
Corresponding author. Mailing address: Institute of
Microbiology, College of Medicine, National Taiwan University, No.1
Sec.1 Jen-Ai Rd., Taipei, Taiwan. Phone: 886-2-2312-3456, ext. 8286. Fax: 886-2-2391-5293. E-mail: wwang60{at}yahoo.com.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»